Combined Therapy in Rheumatoid Arthritis Interstitial Lung Disease RA-ILD is a major therapeutic evidence gap in treat… Read More
RheumNow
Methotrexate significantly lowers Systolic BP jjcush@gmail.com Thu, 09/04/2025 – 10:00 Read More
Abatacept and Methotrexate may Lower Risk of Interstitial Lung Disease in RA jjcush@gmail.com Thu, 09/04/2025 – 10:00 Read More
Retrospective Korean study of #RA & ILD pts (n 151) – ILD duration & UIP pattern significantly… Read More
September is Pulmonary Fibrosis Awareness month. PF & ILD affect more than 250,000 Americans. The Pulmonary Fibrosis… Read More
Biomarkers in ILD Join Elena K. Joerns, MD, as she highlights key insights on the role of… Read More
Elevated serum levels of interleukin-18 discriminate Still’s disease from other autoinflammatory conditions. Sera from 5 https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…… Read More
J&J announced it has halted its combination biologic study in difficult to treat RA. Phase 2a DAISY… Read More
GLP-1 receptor agonists use assoc w/ lower risk of uveitis compared vs controls. EHR study 258 026 ea… Read More
Crepitus Does Not Predict Earlier/Worse OA jjcush@gmail.com Wed, 09/03/2025 – 10:00 Read More